TTNP released positive results for their drug Probuphine in June. Does anyone know the exact month or quarter they plan to resubmit the NDA to the FDA? Hoping they resubmit it soon.
Apaziquone will be submitted for approval this year, according to the company. That's a positive event.
Pernix’s supplemental New Drug Application for Treximet® (sumatriptan / naproxen sodium) for use in adolescent patients, age 12 – 17, for the acute treatment of migraine with or without aura, was accepted for filing with priority review; FDA action is expected by May 14, 2015